February 2013 FDA Recall Drug by Teva Pharmaceuticals Usa, Inc.
D-237-2013 - Failed Content Uniformity Specifications

This Class II drug recall was voluntarily initiated by Teva Pharmaceuticals Usa, Inc. on February 7, 2013 for the product Drug. The FDA reported the reason for recall as failed content uniformity specifications. The product was distributed in NC and the recall is currently terminated.

Recall Number: D-237-2013

Reason for Recall
Failed Content Uniformity Specifications: Recall is being carried out due to an out-of-specification result for content uniformity.
Initiated
02-07-2013
Reported
04-10-2013
Quantity
3 boxes

Recall Profile & Regulatory Data

Class II - is a situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote
Teva Pharmaceuticals USA, Inc.
CLONAZEPAM ORALLY DISINTERGRATING Tablets, USP, 0.5 mg, 60 tablets (10 blister cards of 6 tablets each), TEVA PHARMACEUTICALS USA, Sellersville PA 18960, NDC #0555-0096-96

Batch or Lot Expiration Information

Lot# 32900136A, Exp. 05/14